FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to ophthalmology. To determine the management approach to patients with the latent stage of closed-angle glaucoma and the pigment dispersion syndrome before and after the combined laser iridectomy, the absence or history of the chronic infectious syndrome, systemic allergic syndrome, systemic autoimmune syndrome. Tactics of drug-induced treatment are chosen depending on the obtained total score.
EFFECT: method prevents level of reactive hypertension, iritis, iridocyclitis and optimal rehabilitation period.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SELECTING A METHOD FOR TREATING PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA | 2021 |
|
RU2761048C1 |
| METHOD FOR DETERMINING THE TACTICS OF SURGICAL MANAGEMENT OF PATIENTS WITH A LATENT STAGE OF CLOSED ANGULAR GLAUCOMA | 2020 |
|
RU2741203C1 |
| METHOD OF CARRYING OUT YAG LASER IRIDECTOMY | 2017 |
|
RU2661558C1 |
| METHOD FOR THE TREATMENT OF PIGMENTARY GLAUCOMA | 2021 |
|
RU2759019C1 |
| METHOD FOR TREATING AN ACUTE ATTACK OF ANGLE-CLOSURE GLAUCOMA | 2021 |
|
RU2773802C1 |
| METHOD OF TREATING PRIMARY GLAUCOMA IN PATIENTS WITH ACCOMPANYING ARTERIAL HYPERTENSION | 2015 |
|
RU2607291C1 |
| METHOD FOR COMBINED TREATMENT OF SECONDARY NEOVASCULAR OPEN-ANGLE GLAUCOMA | 2022 |
|
RU2786145C1 |
| METHOD OF LASER TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA | 2007 |
|
RU2340321C1 |
| ALGORITHM OF GLAUCOMA SURGERY IN PATIENTS WITH NATIVE AT ARTIFICIAL LENS | 2015 |
|
RU2609050C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF GEL-LIKE OPHTHALMIC DROPS FOR TREATING GLAUCOMA | 2015 |
|
RU2576778C1 |
